BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21733609)

  • 1. Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam.
    Poulos C; Yang JC; Levin C; Van Minh H; Giang KB; Nguyen D
    Soc Sci Med; 2011 Jul; 73(2):226-34. PubMed ID: 21733609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus.
    Brown DS; Johnson FR; Poulos C; Messonnier ML
    Vaccine; 2010 Feb; 28(7):1702-8. PubMed ID: 20044060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
    Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
    Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands.
    Bogaards JA; Coupé VM; Meijer CJ; Berkhof J
    Vaccine; 2011 Nov; 29(48):8929-36. PubMed ID: 21945961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine.
    Dinh TA; Rosenthal SL; Doan ED; Trang T; Pham VH; Tran BD; Tran VD; Phan GA; Chu HK; Breitkopf CR
    J Adolesc Health; 2007 Jun; 40(6):559-63. PubMed ID: 17531763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy.
    Kim JJ; Kobus KE; Diaz M; O'Shea M; Van Minh H; Goldie SJ
    Vaccine; 2008 Jul; 26(32):4015-24. PubMed ID: 18602731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mothers' willingness to pay for daughters' HPV vaccine in northern Vietnam.
    Dinh Thu H; Nguyen Thanh H; Hua Thanh T; Nguyen Hai L; Tran Thi V; Nguyen Manh T; Buvé A
    Health Care Women Int; 2018 Apr; 39(4):450-462. PubMed ID: 29210616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    de Kok IM; van Ballegooijen M; Habbema JD
    J Natl Cancer Inst; 2009 Aug; 101(15):1083-92. PubMed ID: 19571256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mothers' screening histories influence daughters' vaccination uptake: an analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England.
    Spencer Nee Pilkington AM; Brabin L; Verma A; Roberts SA
    Eur J Cancer; 2013 Apr; 49(6):1264-72. PubMed ID: 23290788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV.
    Alder S; Gustafsson S; Perinetti C; Mints M; Sundström K; Andersson S
    Oncol Rep; 2015 May; 33(5):2521-8. PubMed ID: 25738832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.
    Kahn JA; Ding L; Huang B; Zimet GD; Rosenthal SL; Frazier AL
    Pediatrics; 2009 Jun; 123(6):1439-45. PubMed ID: 19482752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.
    Sheinfeld Gorin SN; Glenn BA; Perkins RB
    Adv Ther; 2011 Aug; 28(8):615-39. PubMed ID: 21818672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D; Wheeler CM
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
    Wong LP
    J Low Genit Tract Dis; 2009 Apr; 13(2):85-93. PubMed ID: 19387128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mothers' Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong.
    Wong CKH; Man KKC; Ip P; Kwan M; McGhee SM
    Value Health; 2018 May; 21(5):622-629. PubMed ID: 29753361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Who will take the blame?": understanding the reasons why Romanian mothers decline HPV vaccination for their daughters.
    Craciun C; Baban A
    Vaccine; 2012 Nov; 30(48):6789-93. PubMed ID: 23017603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.